A new issue of QuarterWatch critiques the recent Ciprani meta-analysis on antidepressants and reports on the adverse effects of the newest antidepressant, vortioxetine.
-
The antidepressants are out of patent now, but it’s popping up again and again that overall, they are not of great value.
